National Cancer Centre, Singapore
Clinical trials sponsored by National Cancer Centre, Singapore, explained in plain language.
-
New combo tackles Drug-Resistant lung cancer
Disease control OngoingThis study tests whether adding a chemotherapy drug called S-1 to the targeted therapy osimertinib can shrink tumors in people with a specific type of lung cancer (EGFR mutant NSCLC) that has stopped responding to treatment. About 30 adults with advanced lung cancer will receive …
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New support role aims to ease tough talks for advanced breast cancer patients
Symptom relief OngoingThis study tests whether a specially trained Patient Support Coordinator (PSC) can help women with advanced or high-risk breast cancer feel heard and understood. The PSC provides emotional support and helps patients share their values and priorities with their medical team. The s…
Phase: NA • Sponsor: National Cancer Centre, Singapore • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC